Why Authentic Novo Nordisk Matters for Your Choice
Genuine Novo Nordisk Wegovy 1.7mg vs Mounjaro Authentication
When comparing 1.7mg Wegovy to Mounjaro, medication authenticity forms the foundation of safe treatment. EverydayMeds sources genuine Novo Nordisk Wegovy exclusively from UK-licensed wholesalers, ensuring every 1.7mg pen bears authentic batch numbers traceable through MHRA systems. The MHRA has issued repeated warnings about counterfeit semaglutide products entering UK markets, making verified supply chains essential. Our authentic Wegovy 1.7mg pens feature distinctive FlexTouch branding, tamper-evident packaging, and batch documentation that confirms pharmaceutical authenticity.
Mounjaro (tirzepatide) carries similar authenticity concerns, though counterfeiting remains less prevalent than with semaglutide products. Both medications require prescription-only access through regulated UK pharmacies registered with the GPhC #9012878. EverydayMeds maintains identical authentication standards for both Wegovy and Mounjaro, ensuring patients receive genuine pharmaceutical products regardless of their treatment choice. Your prescriber can review batch documentation and verify medication authenticity before making treatment recommendations.
1.7mg Wegovy to Mounjaro Pricing and Value Comparison
Authentic Wegovy 1.7mg costs £139.99 per pen at EverydayMeds, representing weeks 13-16 of your dose escalation schedule. The Elevate Duo bundle combines 1.7mg with 2.4mg maintenance doses for £369.99, providing seamless transition to long-term treatment. Returning customers apply code DOSE25 at checkout to maintain optimal pricing throughout their weight management journey. Mounjaro pricing follows different escalation patterns, with costs varying based on dose requirements and treatment duration.
Bundle options optimize value for patients transitioning from 1.7mg Wegovy to maintenance dosing or exploring Mounjaro alternatives. The Consistency 1.7mg bundle provides two identical pens for £309.99, supporting extended treatment at this penultimate dose if side effect management requires slower progression. New patients use code FIRST40 at checkout, whilst established customers benefit from DOSE25 pricing across both Wegovy and Mounjaro options. Both medications require identical assessment fees and delivery costs, making direct price comparison straightforward.
Clinical Evidence Supporting 1.7mg Wegovy vs Mounjaro Decisions
Wegovy 1.7mg represents the penultimate dose before 2.4mg maintenance, with STEP trial data showing progressive weight loss throughout dose escalation phases. Clinical trials demonstrated that patients achieved approximately 15% average weight loss at 68 weeks when taking Wegovy alongside reduced-calorie diets and increased physical activity (Wilding et al., NEJM, 2021). The 1.7mg dose typically produces meaningful appetite suppression whilst maintaining tolerability before final dose escalation.
Mounjaro operates through dual GIP and GLP-1 receptor mechanisms, differentiating its clinical profile from Wegovy's single GLP-1 action. Trial comparisons remain limited due to different study populations and endpoints, preventing direct efficacy comparisons between 1.7mg Wegovy and Mounjaro doses. Both medications demonstrated cardiovascular benefits in respective clinical programmes, though specific outcomes varied based on patient populations and trial designs.
How Wegovy 1.7mg Works Compared to Mounjaro Mechanisms
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones regulating appetite and glucose metabolism. At 1.7mg dosing, semaglutide significantly reduces hunger signals whilst promoting satiety after smaller meals, leading to reduced caloric intake. The medication works primarily through hypothalamic appetite centres, slowing gastric emptying and enhancing glucose-dependent insulin secretion. Unlike Mounjaro's dual mechanism, Wegovy focuses exclusively on GLP-1 pathways, providing targeted appetite regulation. The 1.7mg dose approaches maximum therapeutic effect, preparing patients for 2.4mg maintenance dosing where optimal weight management benefits typically occur. This targeted mechanism makes Wegovy particularly effective for patients whose primary challenge involves appetite control and portion management.
Ordering Authentic 1.7mg Wegovy vs Mounjaro Through EverydayMeds
Both Wegovy 1.7mg and Mounjaro require identical ordering processes beginning with our 3-minute online clinical assessment covering medical history, current medications, and treatment goals. Qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring appropriate medication selection based on individual circumstances. Once approved, both medications ship via next-day cold-chain delivery maintaining pharmaceutical integrity from our GPhC-registered facility #9012878. Temperature-controlled packaging ensures medication potency regardless of weather conditions or delivery timing. Our clinical team remains available throughout treatment to address questions about transitioning between medications or managing side effects during dose escalation phases.
Storage and Practical Differences Between Wegovy 1.7mg and Mounjaro
Genuine Novo Nordisk Wegovy 1.7mg requires refrigeration at 2-8°C until first use, then tolerates up to 6 weeks at room temperature below 30°C, providing significant travel flexibility. Mounjaro offers only 21 days room temperature storage, making Wegovy advantageous for frequent travellers or those with unreliable refrigeration access. Both medications use pre-filled pen devices, though Wegovy's FlexTouch system differs from Mounjaro's pen design in terms of injection mechanism and dose display. Weekly injection scheduling remains identical for both medications, typically administered on the same day each week regardless of timing. The 1.7mg Wegovy dose represents week 13-16 of escalation, whilst Mounjaro follows different titration schedules based on individual tolerance and response patterns. Proper storage ensures authentic medication maintains full potency throughout the treatment period.
Authentic Novo Nordisk Supply Chain vs Counterfeit Risks for Wegovy 1.7mg
EverydayMeds' partnership with licensed UK wholesalers ensures authentic Novo Nordisk Wegovy 1.7mg pens with verifiable batch numbers and manufacturing dates. Counterfeit semaglutide products increasingly target online markets, making verified supply chains essential for patient safety when comparing 1.7mg Wegovy to Mounjaro options. Our authentication process includes packaging inspection, batch verification, and cold-chain documentation from manufacturer to patient delivery. MHRA warnings about fake Wegovy products emphasize the importance of sourcing from registered UK pharmacies rather than unregulated online suppliers.
Mounjaro counterfeiting remains less prevalent but requires identical verification standards to ensure pharmaceutical authenticity and patient safety. Both medications carry significant counterfeiting risks when sourced through unregulated channels, making pharmacy registration and wholesaler licensing critical factors in medication selection. EverydayMeds maintains comprehensive documentation proving authentic sourcing for both Wegovy and Mounjaro, allowing patients to verify medication legitimacy through batch number cross-referencing. This authentication advantage becomes particularly important at the 1.7mg Wegovy dose, where patients approach maintenance therapy requiring long-term treatment reliability.
Making Your 1.7mg Wegovy vs Mounjaro Decision with Confidence
Order authentic Wegovy 1.7mg for £139.99 or explore Mounjaro alternatives through our comprehensive online assessment, with both medications sourced exclusively from genuine UK-licensed suppliers. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 to maintain optimal pricing throughout their weight management journey. Our clinical team provides expert guidance comparing 1.7mg Wegovy mechanisms to Mounjaro's dual receptor approach, helping you make informed decisions based on individual treatment goals and response patterns. Visit https://everydaymeds.co.uk/products/wegovy-1-7mg to begin your assessment or continue your authentic Novo Nordisk treatment journey. Both medications require prescription-only access through our GPhC-registered pharmacy, ensuring safe and legal access to genuine pharmaceutical products. Start your comparison assessment today and discover which authentic medication best supports your long-term weight management objectives.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
